Mar 11, 2019 12:05pm EDT MRI Interventions Reports 36% Increase in Fourth Quarter Revenue and Record Quarterly ClearPoint® Cases
Mar 11, 2019 8:00am EDT MRI Interventions Announces Collaboration with Voyager Therapeutics for the Design, Manufacture and Supply of V-TAG™ Device
Mar 07, 2019 4:05pm EST MRI Interventions Announces Agreement with Siemens Healthineers For Interfacing with the Portfolio of Magnetom MRI Scanners
Mar 06, 2019 5:29pm EST MRI Interventions, Inc. to Announce Fourth Quarter and Full Year 2018 Results on March 11
Jan 03, 2019 4:15pm EST MRI Interventions Announces Estimated 30% Growth Driven by Record Revenue and Record ClearPoint® Procedure Volume in 2018 Fourth Quarter
Jan 03, 2019 4:05pm EST MRI Interventions Receives FDA Clearance for ClearPoint® PURSUIT™ Neuro Aspiration System
Dec 10, 2018 4:42pm EST MRI Interventions Congratulates Voyager Therapeutics on First Patient Dosing in RESTORE-1, the Phase 2 VY-AADC Gene Therapy Trial for Parkinson’s Disease
Nov 12, 2018 4:05pm EST MRI Interventions Reports Record ClearPoint® Cases and Disposable Functional Neurosurgery Revenue in Third Quarter
Nov 06, 2018 4:11pm EST MRI Interventions Announces FDA Clearance of ClearPoint® 2.0 Next-Generation Software Platform